Should You Pick CL Stock At $87?
CL stock, with 12% returns since the beginning of 2024, has underperformed the S&P 500 index, up 27%. The strengthening of ...
Colgate-Palmolive is due for a turnaround, one analyst says. Here’s what can drive it.
Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected ...
Colgate-Palmolive (NYSE:CL) Receives Average Recommendation of “Moderate Buy” from Analysts
Colgate-Palmolive (NYSE:CL – Get Free Report) has received an average rating of “Moderate Buy” from the twenty-two ratings firms that are presently covering the company, Ratings reports. One research ...
Colgate-Palmolive sees weaker annual sales on demand slowdown
Toothpaste maker Colgate-Palmolive forecast annual sales below Wall Street expectations after missing quarterly sales ...
Major brands Nestle, Tyson, Shell, and Colgate added to X lawsuit alleging multi-billion-dollar plot to withhold ad revenue
X added seven companies to its lawsuit Saturday, alleging they partook in a World Federation of Advertisers-coordinated (WFA) ...
Colgate-Palmolive price target lowered to $105 from $110 at Raymond James
Raymond James lowered the firm’s price target on Colgate-Palmolive (CL) to $105 from $110 and keeps an Outperform rating on the shares. The ...
Colgate looking to reduce the impact of possible tariffs on toothpaste made in Mexico
Colgate Palmolive is looking at ways to reduce the impact of possible tariffs on its toothpastes, which the company ...
Colgate-Palmolive EPS Up, Revenue Lags
Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.
J.P. Morgan Sticks to Their Buy Rating for Colgate-Palmolive (CL)
In a report released on February 1, Andrea Faria Teixeira from J.P. Morgan maintained a Buy rating on Colgate-Palmolive (CL – Research Report), ...
Colgate-Palmolive's SWOT analysis: stock faces headwinds amid strong brand portfolio
Colgate-Palmolive (NYSE:CL), a global leader in consumer products with a "GOOD" InvestingPro Financial Health score of 2.73, finds itself at a crossroads as it navigates a complex market environment.